181 results
8-K
EX-99.1
COR
Cencora Inc.
1 May 24
Cencora Reports Fiscal 2024 Second Quarter Results
6:33am
to $13.50 to a range of $13.30 to $13.50.
“Cencora’s critical role at the center of healthcare and the pharmaceutical supply chain was on full display
424B2
COR
Cencora Inc.
7 Feb 24
Prospectus for primary offering
12:00am
to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. More specifically, we distribute … and efficiency of the pharmaceutical supply chain in both human and animal health. More specifically, we distribute a comprehensive offering of brand-name
424B5
COR
Cencora Inc.
5 Feb 24
Prospectus supplement for primary offering
9:43am
patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain … care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both
424B7
0899d1keq6
7 Aug 23
Prospectus with selling stockholder info
5:07pm
424B7
iepra zranlzrs
3 Aug 23
Prospectus with selling stockholder info
5:28pm
SD
EX-1.01
a8nz571
31 May 23
Conflict minerals disclosure
4:11pm
424B7
bqqzp4
8 Nov 22
Prospectus with selling stockholder info
5:25pm
424B7
pvnfep9usvlau 6x4
7 Nov 22
Prospectus with selling stockholder info
5:27pm
8-K
EX-99.1
4cch60ox3hv7907cb4i
7 Nov 22
Other Events
5:10pm
8-K
EX-10.1
omsbzd
27 Oct 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
lqpf2c p9j12
3 Aug 22
Fiscal 2022 Third Quarter Results
6:31am